While heart failure (HF) is an uncommon complication of breast cancer, a new study in the Journal of the American College of Cardiology notes individuals treated with trastuzumab-based chemotherapy have a higher risk for HF—but they are not monitored for it, despite recommendations.

Patients without electrocardiographic (ECG) evidence of left ventricular hypertrophy were significantly more likely to die in the two years after transcatheter aortic valve replacement (TAVR), researchers reported July 30 in Clinical Cardiology.

Individuals at high risk for atrial fibrillation (AFib) who utilized a home-based wearable electrocardiogram (ECG) patch had a higher rate of AFib diagnosis after four months compared to delayed monitoring.

A deep-learning software that can automatically calculate left ventricular ejection fraction (LVEF) with less variability than a cardiologist recently received approval from the U.S. Food and Drug Administration (FDA).

New 2018 guidelines for myocardial perfusion imaging (MPI) protocols on conventional and novel single photon emission computed tomography (SPECT) for nuclear cardiology practitioners has received praise from the Society for Nuclear Medicine and Molecular Imaging (SNMMI).

The U.S. Preventive Services Task Force (USPSTF) issued a Grade D recommendation against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events.

A quantitative measure of stress perfusion by cardiac magnetic resonance (CMR) imaging showed superior ability to predict major adverse cardiac events (MACE) in unselected patients with suspected coronary artery disease (CAD), according to a study published May 7 in JACC: Cardiovascular Imaging.

An expert consensus document published May 2 in the Journal of the American College of Cardiology offers recommendations for limiting radiation exposure to both patients and medical personnel during cardiovascular imaging procedures.